Syndax Pharmaceuticals, Inc. (SNDX)
9.545
0.00 (0.00%)
USD |
NASDAQ |
Nov 09, 16:00
9.545
0.00 (0.00%)
After-Hours: 18:12
Syndax Pharmaceuticals Gross Profit (Annual) : 165.38M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 165.38M |
| December 31, 2024 | 22.85M |
| December 31, 2023 | -0.012M |
| December 31, 2022 | -0.454M |
| December 31, 2021 | 139.25M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | -0.015M |
| December 31, 2013 | -0.013M |
| December 31, 2012 | -0.034M |
| December 31, 2011 | -0.051M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Emergent BioSolutions, Inc. | 350.60M |
| Incyte Corp. | 4.703B |
| Vertex Pharmaceuticals, Inc. | 10.27B |
| Travere Therapeutics, Inc. | 419.65M |